According to Ocular Therapeutix's latest financial reports the company's total assets are $0.25 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.25 B | 68.84% |
2022-12-31 | $0.14 B | -27.14% |
2021-12-31 | $0.20 B | -21.76% |
2020-12-31 | $0.26 B | 232.57% |
2019-12-31 | $78.74 M | 7.8% |
2018-12-31 | $73.04 M | 31.77% |
2017-12-31 | $55.43 M | -26.03% |
2016-12-31 | $74.93 M | -32.06% |
2015-12-31 | $0.11 B | 41.07% |
2014-12-31 | $78.19 M | 308.4% |
2013-12-31 | $19.14 M | -24.28% |
2012-12-31 | $25.28 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
SurModics SRDX | $0.18 B | -28.49% | ๐บ๐ธ USA |
Anika Therapeutics ANIK | $0.27 B | 7.37% | ๐บ๐ธ USA |
Intersect ENT XENT | N/A | N/A | ๐บ๐ธ USA |
Haemonetics HAE | $2.20 B | 772.98% | ๐บ๐ธ USA |